Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors $18.70 +0.76 (+4.24%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$18.43 -0.27 (-1.42%) As of 05/2/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock TLX vs. SMMT, TEVA, ITCI, GMAB, RDY, MRNA, ASND, VTRS, QGEN, and ROIVShould you be buying Telix Pharmaceuticals Limited American Depositary Shares stock or one of its competitors? The main competitors of Telix Pharmaceuticals Limited American Depositary Shares include Summit Therapeutics (SMMT), Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Ascendis Pharma A/S (ASND), Viatris (VTRS), Qiagen (QGEN), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Telix Pharmaceuticals Limited American Depositary Shares vs. Summit Therapeutics Teva Pharmaceutical Industries Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Moderna Ascendis Pharma A/S Viatris Qiagen Roivant Sciences Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) and Summit Therapeutics (NASDAQ:SMMT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability. Is TLX or SMMT more profitable? Telix Pharmaceuticals Limited American Depositary Shares' return on equity of 0.00% beat Summit Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Telix Pharmaceuticals Limited American Depositary SharesN/A N/A N/A Summit Therapeutics N/A -85.42%-52.66% Which has higher valuation and earnings, TLX or SMMT? Telix Pharmaceuticals Limited American Depositary Shares has higher revenue and earnings than Summit Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelix Pharmaceuticals Limited American Depositary Shares$783.21M8.07N/AN/AN/ASummit Therapeutics$700K29,401.82-$614.93M-$0.31-90.00 Do analysts recommend TLX or SMMT? Telix Pharmaceuticals Limited American Depositary Shares presently has a consensus target price of $22.00, suggesting a potential upside of 17.65%. Summit Therapeutics has a consensus target price of $37.40, suggesting a potential upside of 34.05%. Given Summit Therapeutics' higher probable upside, analysts plainly believe Summit Therapeutics is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Telix Pharmaceuticals Limited American Depositary Shares 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Summit Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of TLX or SMMT? 4.6% of Summit Therapeutics shares are owned by institutional investors. 88.3% of Summit Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community favor TLX or SMMT? Summit Therapeutics received 308 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 58.65% of users gave Summit Therapeutics an outperform vote. CompanyUnderperformOutperformTelix Pharmaceuticals Limited American Depositary SharesOutperform Votes4100.00% Underperform VotesNo VotesSummit TherapeuticsOutperform Votes31258.65% Underperform Votes22041.35% Does the media favor TLX or SMMT? In the previous week, Summit Therapeutics had 14 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 23 mentions for Summit Therapeutics and 9 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Summit Therapeutics' average media sentiment score of 0.55 beat Telix Pharmaceuticals Limited American Depositary Shares' score of 0.05 indicating that Summit Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Telix Pharmaceuticals Limited American Depositary Shares 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Summit Therapeutics 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummarySummit Therapeutics beats Telix Pharmaceuticals Limited American Depositary Shares on 8 of the 12 factors compared between the two stocks. Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLX vs. The Competition Export to ExcelMetricTelix Pharmaceuticals Limited American Depositary SharesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.32B$6.85B$5.56B$8.04BDividend YieldN/A2.95%5.09%4.22%P/E RatioN/A7.4422.6918.83Price / Sales8.07257.63404.28106.72Price / CashN/A65.8538.1834.62Price / BookN/A6.576.794.33Net IncomeN/A$143.14M$3.22B$247.97M7 Day Performance-0.53%3.48%3.37%3.18%1 Month Performance15.79%10.49%6.95%8.13%1 Year PerformanceN/A-3.31%16.13%5.01% Telix Pharmaceuticals Limited American Depositary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$18.70+4.2%$22.00+17.6%N/A$6.32B$783.21M0.00N/AAnalyst RevisionNews CoverageSMMTSummit Therapeutics2.6797 of 5 stars$24.11+2.7%$37.50+55.5%+587.2%$17.79B$700,000.00-86.10110Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading VolumeTEVATeva Pharmaceutical Industries3.1298 of 5 stars$15.03+1.1%$23.43+55.9%+15.2%$17.04B$16.54B-10.3736,800Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsGap UpITCIIntra-Cellular Therapies0.881 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560Upcoming EarningsAnalyst ForecastGMABGenmab A/S4.4648 of 5 stars$20.63+0.2%$39.17+89.9%-22.5%$13.66B$21.53B11.861,660Upcoming EarningsPositive NewsRDYDr. Reddy's Laboratories1.7098 of 5 stars$13.95+1.2%$17.00+21.9%-6.4%$11.65B$311.31B22.2124,800Upcoming EarningsPositive NewsMRNAModerna4.3617 of 5 stars$27.46+0.9%$58.70+113.8%-78.0%$10.62B$3.20B-2.963,900Earnings ReportAnalyst ForecastNews CoverageGap UpASNDAscendis Pharma A/S2.1563 of 5 stars$164.88+0.4%$204.67+24.1%+21.9%$10.05B$363.64M-23.22640Earnings ReportAnalyst ForecastNews CoverageVTRSViatris1.6937 of 5 stars$8.25+1.5%$10.50+27.3%-25.4%$9.85B$14.74B-11.1537,000Upcoming EarningsQGENQiagen3.8165 of 5 stars$42.49+1.0%$47.83+12.6%+4.0%$9.45B$1.98B118.316,030Upcoming EarningsGap UpROIVRoivant Sciences2.2192 of 5 stars$11.19+1.6%$17.50+56.4%+2.1%$7.98B$122.59M-74.60860 Related Companies and Tools Related Companies SMMT Alternatives TEVA Alternatives ITCI Alternatives GMAB Alternatives RDY Alternatives MRNA Alternatives ASND Alternatives VTRS Alternatives QGEN Alternatives ROIV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals Limited American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLX Stock Free TLX Stock Alerts